What this means
Researchers plan to compare frailty in men and women with a fatty liver condition called MASLD. They want to see how frailty changes over time and what it connects to.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 20–80
- Where
- 2 sites
The science
- Registered title
- Impact of Steatotic Liver Disease Associated With Metabolic Dysfunction (MASLD) on Frailty, Cognition, and Quality of Life. A Gender-sensitive Approach Towards a Comprehensive and Equitable Perspective.
- Trial ID
- NCT07652892 ↗
- Phase
- Not applicable
- Study type
- observational
- Conditions
- Steatosis of Liver
- Sponsor
- Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- Ages
- 20 Years to 80 Years
- Dates
- First posted Jun 17, 2026 · updated Jun 17, 2026
Registry summary
The goal of this observational study is to determine the differences in the prevalence, characteristics and evolution of frailty between men and women diagnosed with MASLD, and to establish its relationship with clinical, functional, hormonal and social parameters.
Sites (2)
- Hospital de la Santa Creu i Sant Pau, Barcelona, Barcelona, Spain
- Hospital de la Santa Creu i Sant Pau, Barcelona, Barcelona, Spain